Article
Genotype-driven therapeutic developments in Parkinson's disease.
Molecular medicine (Cambridge, Mass.) - 19 Apr 2021
Prasuhn Jannik, Brüggemann Norbert
Abstract excerpt
BACKGROUND: Remarkable advances have been reached in the understanding of the genetic basis of Parkinson's disease (PD), with the identification of monogenic causes (mPD) and a plethora of gene loci leading to an increased risk for idiopathic PD. The expanding knowledge and subsequent identification of genetic contributions fosters the understanding of molecular mechanisms leading to disease development and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
